Bendamustine Hydrochloride
Product Images NDC 68001-571

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bendamustine Hydrochloride (NDC 68001-571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg Carton (Bendamustine 100mg Carton)

Packaging label for Bendamustine Hydrochloride for Injection, USP 100 mg/vial by BluePoint Laboratories. The label states it is for intravenous infusion only, requires reconstitution and dilution as per insert, and the vial is sterile and single-dose. It includes storage instructions, cytotoxic agent warning, and manufacturer information, Intas Pharmaceuticals Limited, India.*

FDA Label Image

100mg Vial (Bendamustine 100mg Label)

Label for Bendamustine Hydrochloride for Injection, USP 100 mg per vial by BluePoint Laboratories. The label includes reconstitution instructions to 20 mL sterile water for injection, storage guidance, and manufacturer information. It is marked for intravenous infusion use only and single-dose vial indication. Lot and expiration area is reserved blank for overcoding.*

FDA Label Image

25mg Carton (Bendamustine 25mg Carton)

Label for Bendamustine Hydrochloride for Injection, USP, 25 mg/vial, by BluePoint Laboratories. The sterile single-dose vial label includes instructions for intravenous infusion, reconstitution, and dilution. It states to discard unused portions and retain the vial in the carton until use. Additional storage and preparation cautions are printed on the label.*

FDA Label Image

25ml Vial Label (Bendamustine 25mg Label)

Label for Bendamustine Hydrochloride for Injection, USP 25 mg/vial by BluePoint Laboratories. The label indicates a sterile single-dose vial for intravenous infusion, with storage and preparation instructions, and includes manufacturer information (Intas Pharmaceuticals Limited, India). The label features barcodes and NDC 68001-571-41.*

FDA Label Image

Figure 1. Progression-free Survival (Bendamustine Fig 1)

A Kaplan-Meier survival curve chart showing progression-free survival (in months) on the x-axis and survival distribution function on the y-axis, comparing bendamustine hydrochloride treatment to chlorambucil treatment. The graph uses solid and dashed lines to differentiate the two study treatments.*

FDA Label Image

Structural Formula (Bendamustine Structure)

Chemical structure of bendamustine hydrochloride, showing its molecular arrangement with chlorobutyl side chains and a substituted purine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.